Ethyl 2-oxocyclopentanecarboxylate

Ethyl 2-oxocyclopentanecarboxylate is a highly reactive bifunctional specialty fine chemical, primarily serving as an advanced pharmaceutical intermediate and a key structural precursor for the synthesis of the global blockbuster non-steroidal anti-inflammatory and analgesic drug, Loxoprofen Sodium.

Target Specifications:

Target Assay (GC): ≥ 99.0%

Target Appearance: Colorless to very pale yellow transparent liquid

Process Route Design & Expected Technical Advantages: Addressing industry pain points common in traditional bulk products, such as yellowing, complex impurity profiles, and high solvent residues, our company leverages a proprietary continuous purification platform to reconstruct and optimize the synthesis and purification processes at the foundational level. Our CDMO solution aims to resolve the following core challenges for downstream advanced pharmaceutical enterprises:

1. Ultra-Short Thermal History Design (Focused on Improving Color): Traditional processes are limited by crude heating modes, which easily induce thermal condensation and polymerization leading to yellowing. Our process route introduces the concept of ultra-short thermal history control, aiming to physically reduce high-temperature residence time and significantly lower the incidence of side reactions. The expected outcome of this route is a clear and bright liquid, which is expected to help downstream customers reduce or even eliminate decolorization steps.

2. Deep Intervention of Reaction Equilibrium (Focused on Breaking Purity Bottlenecks): Addressing the difficult-to-break chemical equilibrium issues in the synthesis of this molecule, this route adopts innovative strong intervention methods for reaction equilibrium. By achieving efficient removal of by-products under mild conditions, our process design aims to break through the traditional purity ceiling of 95%-97%, consistently achieving and maintaining chromatographic-grade purity above 99.0%.

3. Deep Pressure Differential Solvent Removal System (Focused on Strict Control of Solvent Residues): In response to the red-line requirements of the pharmaceutical supply chain regarding carcinogenic solvent residues, this plan intends to implement a deep pressure differential continuous solvent removal process. Within the safe temperature range that ensures product color, our goal is to suppress residues of light components such as toluene to extremely low levels far below standard market grade. Additionally, the full-process micron-level fluid purification design aims to ensure the purity of the final delivery system, providing solid technical support for customer compliance audits.

Source Factory & Proprietary Continuous Flow Technology Advantages

NINGBO INNO PHARMCHEM CO.,LTD., as a source manufacturer, possesses self-developed and self-designed pipeline continuous flow reaction equipment. Compared to traditional batch reactions, our continuous flow microchannel technology offers excellent batch stability and inherent safety characteristics, effectively avoiding quality fluctuations caused by scale-up effects. We sincerely invite domestic and international trading companies and end-users to establish long-term strategic partnerships, jointly develop the pharmaceutical and agrochemical intermediate market, and provide one-stop custom manufacturing services from gram-scale R&D to ton-scale delivery.